about
The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathwayThe TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese womenEffect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial.Gas chromatography/atmospheric pressure chemical ionization/mass spectrometry for the analysis of organochlorine pesticides and polychlorinated biphenyls in human serum.Effects of Changing the Amount and Source of Dietary Carbohydrates on Symptoms and Dietary Satisfaction Over a 1-Year Period in Subjects with Type 2 Diabetes: Canadian Trial of Carbohydrates in Diabetes (CCD).Increased subcutaneous adipose tissue expression of genes involved in glycerolipid-fatty acid cycling in obese insulin-resistant versus -sensitive individualsCFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cellsThe Effect of a Breakfast Rich in Slowly Digestible Starch on Glucose Metabolism: A Statistical Meta-Analysis of Randomized Controlled TrialsFTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction.Association between Abdominal Fat (DXA) and Its Subcomponents (CT Scan) before and after Weight Loss in Obese Postmenopausal Women: A MONET StudyGenetic variation and statistical considerations in relation to overfeeding and underfeeding in humans.Prevention of type 2 diabetes: insulin resistance and beta-cell function.Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.Characteristics of metabolically obese normal-weight (MONW) subjects.Barriers to physical activity among patients with type 1 diabetes.Influence of cardiorespiratory fitness and physical activity levels on cardiometabolic risk factors during menopause transition: A MONET study.Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation.Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.Carotid femoral pulse wave velocity in type 2 diabetes and hypertension: capturing arterial health effects of step counts.Menopause and sarcopenia: A potential role for sex hormones.Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group.Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary).The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary.The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.Lifestyle and cardiometabolic risk in adults with type 1 diabetes: a review.Could T cells be involved in lung deterioration and hyperglycemia in cystic fibrosis?Diabetic mastopathy: case report and summary of literature.Body composition, cardiometabolic risk factors, physical activity, and inflammatory markers in premenopausal women after a 10-year follow-up: a MONET study.Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes.Practices, perceptions and expectations for carbohydrate counting in patients with type 1 diabetes - Results from an online survey.Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use.Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges.The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.What Is Known About the Correlates and Impact of Excess Skin After Bariatric Surgery: a Scoping Review.Treatment of Hypoglycemia in Adult Patients with Type 1 Diabetes: An Observational Study.Comparison of Two Continuous Glucose Monitoring Systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite System, at Rest and During Exercise.CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells.Effects of a weight loss program on body composition and the metabolic profile in obese postmenopausal women displaying various obesity phenotypes: a MONET group study.Pharmacokinetic analysis of absorption, distribution and disappearance of ingested water labeled with D₂O in humans.
P50
Q24648295-89E0BB10-BF8F-4FF0-81CD-55A6437F2771Q28396618-56EB8D19-3994-4868-A9A1-0CDDB002553FQ33390806-2EA1ABD3-06DF-47BD-8D3A-9D8CFE255596Q33468039-692DD22F-DB0E-42BE-ADBE-641259FA2B65Q33469325-A297AEDB-B7FD-486C-A981-04A3A2AD2E89Q33570114-8F38FF49-47E1-47D7-8DB0-EF39AD0D76CDQ33576842-E351D3CC-2A2A-4189-8C04-A11CD7E7CFB5Q33616524-14241DCE-EDAF-4AC0-8F77-CDE02951BEDEQ34448692-6BC6B5B8-2CDC-42D6-AE9E-DE29FDA0DCBDQ34974413-BF82B7E5-A942-404F-B9BF-0A579AD911E3Q35617574-8EDDD083-D166-4C67-B308-A4A7FE743F37Q35961989-9A7F9F75-F357-4F11-955B-2F07EAEA2F35Q36659766-7465E9A9-7DE8-4AFD-B2D8-166E5B2AE238Q36749229-1B3ECFBE-D5DE-49BB-A25E-7B2D9ED44028Q36945270-9133A606-4528-4862-9828-100BAD35908FQ37089408-250C1D42-CD60-45D3-BD80-F56F4B9AF318Q37421571-A98E29D3-DA8D-4197-9E43-9F4C368873BFQ37470271-F387EF1F-5557-4970-A8DB-5945926396B0Q37735313-9EECC77B-FC14-45CD-A229-E703401542DDQ37847363-CA805D4D-9E78-4849-86F0-05B893DE80B5Q37860653-4D01B87E-0051-4041-9151-4BD540477CCCQ37860655-6FA5BE43-186B-405E-9468-CF72DB276441Q37860662-1F029E39-76F4-4B3F-BDF2-35F977FD625BQ37884681-1F84310D-D4CF-4774-84C0-7B23C282C1EDQ38184090-61EC88D6-6AE1-4795-BD02-1A4EFA7D38CFQ38204510-00695710-485F-4382-BDD6-E04B237F9388Q38211379-22F3B8D8-9D72-42B7-909F-DD8916C9CD91Q38649325-98B13571-F811-41E4-BDA3-7DC81BB70BBFQ38746353-B26345F2-3DE1-49F4-886A-783599B235F6Q38748736-56A25AD0-4880-44C2-9C4B-52E57BC07053Q38821167-37F7B1EF-B22A-4363-9343-8EE41C8D9046Q38979834-BDDDC813-E730-4EBF-B4EC-2A56561CAD2FQ38980646-C94A1562-B24B-4C50-82E7-26878E48BD26Q39413453-0B9C6E33-E459-48DC-9299-08215372C300Q39417353-6E9FB66C-8752-4D08-9402-03154B4ED38BQ39635994-0F9ED76A-AF0A-4009-8105-AF1559138B9BQ39645480-E6B1D9A1-7164-4AE1-9901-B3B481184B95Q39790745-84D4C1BA-2014-4A88-A5C5-B6942E7E0F67Q40770889-5E4E2AD1-7463-4193-9F41-BD02845DC7F7Q42115421-65C1F225-A8F2-4403-9DB1-DB2367A14112
P50
description
researcher ORCID ID = 0000-0003-4706-5170
@en
wetenschapper
@nl
name
Rémi Rabasa-Lhoret
@ast
Rémi Rabasa-Lhoret
@en
Rémi Rabasa-Lhoret
@nl
type
label
Rémi Rabasa-Lhoret
@ast
Rémi Rabasa-Lhoret
@en
Rémi Rabasa-Lhoret
@nl
prefLabel
Rémi Rabasa-Lhoret
@ast
Rémi Rabasa-Lhoret
@en
Rémi Rabasa-Lhoret
@nl
P31
P496
0000-0003-4706-5170